A detailed history of Blackhawk Capital Partners Llc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Blackhawk Capital Partners Llc. holds 6,411 shares of NVO stock, worth $544,935. This represents 0.41% of its overall portfolio holdings.

Number of Shares
6,411
Previous 6,160 4.07%
Holding current value
$544,935
Previous $879,000 13.2%
% of portfolio
0.41%
Previous 0.54%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $29,886 - $36,500
251 Added 4.07%
6,411 $763,000
Q2 2024

Jul 29, 2024

BUY
$122.71 - $146.91 $285,791 - $342,153
2,329 Added 60.79%
6,160 $879,000
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $12,661 - $16,854
124 Added 3.35%
3,831 $491,000
Q4 2023

Jan 19, 2024

BUY
$87.78 - $105.45 $325,400 - $390,903
3,707 New
3,707 $383,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Blackhawk Capital Partners Llc. Portfolio

Follow Blackhawk Capital Partners Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

News

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.